Esperion’s Top Holder Buys $5.2 Million More in Stock
May 23, 2018 at 11:11 AM EDT
Esperion Therapeutics' largest shareholder, BB Biotech of Switzerland, bought $5.2 million more in shares of the biotech after they collapsed earlier this month.
